Plasma lncRNA FEZF1-AS1 as a potential biomarker for diagnosis of non-small-cell lung carcinoma

Diagnosis of numerous cancers has been closely linked to the expression of certain long non-coding RNAs. This study aimed to evaluate levels of plasma FEZ family zinc finger 1 antisense RNA 1 (FEZF1-AS1) relative to non-small-cell lung carcinoma (NSCLC) diagnosis. The level of FEZF1-AS1 in the blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yajie, Liu, Guangjie, Ma, Handie, Tian, Yanpeng, Huang, Changjie, Liu, Fang, Jia, Yuxuan, Jiang, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329120/
https://www.ncbi.nlm.nih.gov/pubmed/32590821
http://dx.doi.org/10.1097/MD.0000000000021019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329120/
https://www.ncbi.nlm.nih.gov/pubmed/32590821
http://dx.doi.org/10.1097/MD.0000000000021019

Ejemplares similares